Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata with no full letter text available, this warning letter was issued to Glint Cosmetics Pvt Ltd on May 31, 2019, regarding drug products under FDA jurisdiction. While the specific violations cannot be determined from the available metadata, the warning indicates regulatory concerns with the company's drug manufacturing, labeling, or marketing practices. The letter represents FDA enforcement action within the drug product category, though the issuing office and detailed violation count are not specified in the available information.